Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 23.83B 3.57B 3.19B 2.93B 2.66B 5B 338B 5.12B 34.97B 14.07B 179B 13.4B 13.11B 566B P/E 2026 *
16.6x
P/E 2027 * 14x
Enterprise Value 20.71B 3.1B 2.77B 2.55B 2.31B 4.34B 294B 4.45B 30.4B 12.23B 155B 11.65B 11.4B 492B EV / Sales 2026 *
0.69x
EV / Sales 2027 * 0.62x
Free-Float
37.06%
Yield 2026 *
4.5%
Yield 2027 * 4.99%
1 day+1.80%
1 week+10.11%
Current month+3.26%
1 month+14.95%
3 months+10.98%
6 months+11.75%
Current year+18.73%
1 week 18.12
Extreme 18.12
21.16
1 month 17.74
Extreme 17.74
21.16
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 2019-02-27
Director of Finance/CFO 44 2018-05-09
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 2013-07-15
Director/Board Member 63 2016-08-07
Chairman 48 2015-05-27
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+10.11%+14.44%-14.23% 3.52B
+1.72%+6.59%-33.87%+13.55% 16.04B
+0.75%-1.26%-6.05%-0.76% 6.54B
+1.81%+1.13%-14.96%+2.87% 6.55B
+2.78%+3.87%-49.05%-36.99% 5.92B
-18.69%-7.68%-23.36%-40.09% 4.89B
+2.63%+7.09%+11.96%-4.85% 4.86B
-1.04%+3.39%-22.44%-33.30% 3.15B
+0.61%+3.88%-21.12%+28.97% 3.1B
-0.50%-5.94%-13.00%-24.03% 3.01B
Average -0.82%+0.63%-15.75%-10.89% 5.76B
Weighted average by Cap. -0.26%+1.09%-20.01%-6.00%

Financials

2026 *2027 *
Net sales 29.85B 4.47B 4B 3.67B 3.33B 6.26B 424B 6.42B 43.82B 17.63B 224B 16.79B 16.43B 709B 32.52B 4.87B 4.35B 4B 3.63B 6.82B 462B 6.99B 47.74B 19.21B 244B 18.29B 17.9B 772B
Net income 1.47B 220M 196M 180M 164M 307M 20.8B 315M 2.15B 865M 10.98B 824M 807M 34.8B 1.72B 257M 230M 211M 192M 360M 24.36B 369M 2.52B 1.01B 12.86B 965M 945M 40.76B
Net Debt -3.12B -467M -417M -383M -348M -654M -44.26B -670M -4.58B -1.84B -23.36B -1.75B -1.72B -74.04B -3.76B -563M -503M -462M -419M -788M -53.3B -807M -5.51B -2.22B -28.13B -2.11B -2.07B -89.17B
Projected Income Statement - Annual - DaShenLin Pharmaceutical Group Co., Ltd.
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
26-11-02 CN¥20.92 +1.80% 25,937,990
26-11-02 CN¥20.55 +1.43% 34,668,330
26-10-30 CN¥20.26 +9.99% 23,947,044
26-10-29 CN¥18.42 -0.16% 7,726,262
26-10-28 CN¥18.45 -0.16% 8,377,030
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
20.92CNY
Average target price
23.99CNY
Spread / Average Target
+14.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock